Transamerica Financial Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Transamerica Financial Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-14	Closed	-$2K	–	316
2020 Q2	$2K	Buy	+14	New	+$1.78K	﹤0.01%	314
2018 Q4	–	Sell	-22,387	Closed	-$2.73M	–	523
2018 Q3	$2.73M	Buy	+22,387	New	+$2.64M	0.58%	43
2017 Q4	–	Sell	-21,873	Closed	-$2.43M	–	443
2017 Q3	$2.43M	Buy	+21,873	New	+$2.34M	0.3%	103
2017 Q1	–	Sell	-3	Closed	-$1K	–	412
2016 Q4	$1K	Buy	+3	New	+$273	﹤0.01%	364
2016 Q2	–	Sell	-900	Closed	-$79K	–	531
2016 Q1	$79K	Buy	+900	New	+$80.5K	0.01%	331
2015 Q2	–	Sell	-138	Closed	-$16K	–	909
2015 Q1	$16K	Buy	+138	New	+$15.2K	﹤0.01%	568

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Transamerica Financial Advisors's IBB Position: Q3 2020 in Review

Transamerica Financial Advisors sold out of iShares Biotechnology ETF (IBB) in Q3 2020, closing a stake of 14 shares — an estimated $2K sold.

Transamerica Financial Advisors first reported a position in IBB in Q1 2015 and held it in 6 quarters. The position peaked at $2.73M in Q3 2018. 784 funds tracked by Wall St. Rank hold IBB as of Q3 2020.

Transamerica Financial Advisors reported no remaining iShares Biotechnology ETF position as of Q3 2020 after selling out during the quarter.
Transamerica Financial Advisors sold 14 iShares Biotechnology ETF shares in Q3 2020, an estimated $2K.
Transamerica Financial Advisors first reported a position in iShares Biotechnology ETF in Q1 2015 and held it in 6 quarters.
Transamerica Financial Advisors's iShares Biotechnology ETF position peaked at $2.73M in Q3 2018.
784 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2020.

Based on Transamerica Financial Advisors's 13F filing for Q3 2020, filed 12 Nov 2020.